Atlas Trials

Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT00655603 · UNKNOWN

Trial details

NCT number
NCT00655603
Sponsor
University Hospital, Gentofte, Copenhagen
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2008-03-01
Primary completion
2009-05-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.